Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data.
Tomida R, Takahashi M, Matsushita Y, Kojima T, Yamana K, Kandori S, Bando Y, Nishiyama N, Yamashita S, Taniguchi H, Monji K, Ishiyama R, Tatarano S, Masui K, Matsuda A, Kaneko T, Motoshima T, Shiraishi Y, Kira S, Murashima T, Hara H, Matsumura M, Kitamura H, Miyake H, Furukawa J; Japanese Urological Oncology Group. Tomida R, et al. Among authors: masui k. Clin Genitourin Cancer. 2024 Apr 15:102094. doi: 10.1016/j.clgc.2024.102094. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 38714434
Spatial Pattern of Intraprostatic Recurrence after Definitive External-Beam Radiation Therapy for Prostate Cancer: Implications for Focal Boost to Intraprostatic Dominant Lesion.
Aizawa R, Otani T, Ogata T, Moribata Y, Kido A, Akamatsu S, Goto T, Masui K, Sumiyoshi T, Kita Y, Kobayashi T, Nakamoto Y, Mizowaki T. Aizawa R, et al. Among authors: masui k. Adv Radiat Oncol. 2024 Mar 13;9(6):101489. doi: 10.1016/j.adro.2024.101489. eCollection 2024 Jun. Adv Radiat Oncol. 2024. PMID: 38681892 Free PMC article.
Reirradiation for recurrent gynecologic cancer using high-dose-rate brachytherapy in Japan: A multicenter survey on practice patterns and outcomes.
Isohashi F, Yoshida K, Murakami N, Masui K, Ishihara S, Ohkubo Y, Kaneyasu Y, Kinoshita R, Kotsuma T, Takaoka Y, Tanaka E, Nagao A, Ogawa K, Yamazaki H. Isohashi F, et al. Among authors: masui k. Radiother Oncol. 2024 Apr 5;195:110269. doi: 10.1016/j.radonc.2024.110269. Online ahead of print. Radiother Oncol. 2024. PMID: 38583719
Association Between Pretreatment 11C-Methionine Positron Emission Tomography Metrics, Histology, and Prognosis in 125 Newly Diagnosed Patients with Adult-Type Diffuse Glioma Based on the World Health Organization 2021Classification.
Kaneko K, Koriyama S, Tsuzuki S, Masui K, Kanasaki R, Yamamoto A, Nagao M, Muragaki Y, Kawamata T, Sakai S. Kaneko K, et al. Among authors: masui k. World Neurosurg. 2024 Apr 5:S1878-8750(24)00550-3. doi: 10.1016/j.wneu.2024.03.164. Online ahead of print. World Neurosurg. 2024. PMID: 38583563
Hands-on-training tailored in response to pre-questionnaire-based survey on image-guided brachytherapy effectively reduces anxiety about its implementation.
Okonogi N, Murakami N, Takatsu J, Iijima K, Kawamoto T, Oshima M, Okuma K, Masui K, Murata K, Okamoto H, Yoshida K, Noda SE, Numajiri H, Watanabe M, Tsuchida K, Muramoto Y, Karino T, Ohno T, Shikama N. Okonogi N, et al. Among authors: masui k. J Radiat Res. 2024 Mar 27:rrae013. doi: 10.1093/jrr/rrae013. Online ahead of print. J Radiat Res. 2024. PMID: 38544297 Free article.
DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma.
Harachi M, Masui K, Shimizu E, Murakami K, Onizuka H, Muragaki Y, Kawamata T, Nakayama H, Miyata M, Komori T, Cavenee WK, Mischel PS, Kurata A, Shibata N. Harachi M, et al. Among authors: masui k. Acta Neuropathol Commun. 2024 Mar 13;12(1):40. doi: 10.1186/s40478-024-01750-x. Acta Neuropathol Commun. 2024. PMID: 38481314 Free PMC article.
395 results